|
|
 |
|
Viewing report
|
|
|
|
U.S. Market for Interventional Ophthalmic Devices 2011
iData Research, Feb 2011, Pages: 195
The total U.S. interventional ophthalmic device market is expected to reach nearly $2 billion by 2017.
The U.S. interventional ophthalmic device market includes:
- intraocular lenses,
- ophthalmic lasers,
- photorefractive lasers,
- phacoemulsification consoles,
- vitrectomy consoles,
- glaucoma shunts,
- microkeratomes,
- femtosecond lasers and
- ophthalmic viscosurgical devices
The largest segment was intraocular lenses, which consists of monofocal, multifocal and accommodative lenses. Intraocular lenses are expected to grow due to the increasing demand for premium lenses.
Within the interventional ophthalmic device market, companies such as Abbott Medical Optics, Alcon, Bausch & Lomb, Lumenis, Iridex and Carl Zeiss Meditec lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
The executive summary of this report is also available.
Keywords:
intraocular lenses, ophthalmic lasers, photorefractive lasers, phacoemulsification consoles, vitrectomy consoles, glaucoma shunts, microkeratomes, femtosecond lasers and ophthalmic viscosurgical devices
Also available
U.S. Market for Interventional Ophthalmic Devices 2011 (Executive Summary)
|
|
|
|
